An Open Letter to Officials of the National Institute of Mental Health

The National Institute of Mental Health (NIMH) has issued an inaccurate, obfuscating, and misleading statement ON April 23, 2004 — Antidepressant Medications for Children: Information for Parents and Caregivers — that continues to encourage the use of antidepressants for children: “Many times, psychotherapy accompanied by an early follow- up appointment may help to establish the persistence of depression before a decision is made to try antidepressant medications.” This statement appears to demonstrate the inordinate influence of Big Pharma on NIMH.

NIH Rule change Re: Whistle blowers – Comments due before June 15

A request for comment about NIH proposed new research misconduct rule

See Fed Register:

The new rule, I believe is meant to protect research institutions from the effective sting of a knowledgeable whistle blower.

The new rule would redefine whistle-blower as “complainant” and would limit the role of the complainant. Under the old rule, the whistle-blower participated in the process helping investigators by leading them to the evidence, etc.